Discover what a decade of follow-up reveals about umbilical cord–derived mesenchymal stem cells (UC-MSCs) for Systemic Sclerosis (SSc/scleroderma). In this video, Dr. David Greene R3 Stem Cell (MD, PhD, MBA) explains the design, outcomes, and real-world relevance of a 10-year study—a rare time horizon in regenerative research. You’ll learn how UC-MSCs may help modulate immune activity and fibrosis, what to expect from an evaluation, and how image-guided delivery and customized protocols are used in R3’s global clinics.
Comments